News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Opportunistic infections news

Show

From To
Side-effects
Diarrhoea remains a common problem in people with HIV

Diarrhoea remains common in people with HIV and usually has a non-infectious cause, according to a review article published in the online edition of Clinical Infectious Diseases. The

Published
06 July 2012
By
Michael Carter
TB prevention
HIV and TB in Practice for nurses: cotrimoxazole prophylaxis

Cotrimoxazole prophylaxis is the use of a common antiobiotic to prevent a range of infections that commonly affect people living with HIV.

Published
23 June 2012
From
HIV & AIDS treatment in practice
Opportunistic infections
FDA Approves Foscarnet for HIV-Related CMV Retinitis, Herpes

The US Food and Drug Administration (FDA) has approved foscarnet sodium injection (Foscavir, Clinigen) for the treatment of HIV/AIDS-related cytomegalovirus (CMV) infections and herpes.

Published
11 May 2012
From
Medscape (requires registration)
Cardiovascular disease
Does CMV underlie the increased risk of cardiovascular disease in patients with HIV?

Cytomegalovirus (CMV) antibody levels are associated with some important markers of vascular disease in HIV-positive women, US researchers show in a study published in the online edition

Published
16 April 2012
By
Michael Carter
Opportunistic infections
'Social networks' may explain high prevalence of MRSA colonization seen in patients with HIV

Infection with HIV per se does not increase the risk of colonisation with community-associated MRSA, according to US research published in the online edition of Clinical

Published
27 February 2012
By
Michael Carter
Opportunistic infections
Cotrimoxazole prophylaxis reduces death rate by almost 60% in adults taking ART in low and middle-income countries

Cotrimoxazole significantly reduces death among adults on ART in low and middle-income countries, according to a systematic review and meta-analysis published in the October online edition of

Published
10 February 2012
By
Carole Leach-Lemens
Opportunistic infections
Cotrimoxazole prophylaxis is cost-effective for people starting ART in sub-Saharan Africa

Achieving full coverage of cotrimoxazole prophylaxis during the first six months of antiretroviral therapy would be a highly cost-effective way of reducing early death among those with advanced

Published
10 February 2012
By
Carole Leach-Lemens
Opportunistic infections
First-Ever Treatment Guidelines Released for Major Cause of Death of People Living with HIV

The World Health Organization (WHO) has issued the first-ever guidelines for the treatment of cryptococcal meningitis – a disease ranking among the top causes of death among people living with HIV/AIDS. However, access to some of the WHO-recommended medicines ranges from difficult to non-existent in developing countries.

Published
13 December 2011
From
MSF
Opportunistic infections
New vaccine against pneumococcal disease approved for UK

A new vaccine that may be more suitable for preventing pneumococcal disease in people living with HIV has been approved in the United Kingdom. Prevenar 13, manufactured by

Published
30 November 2011
By
Keith Alcorn
Opportunistic infections
HIV-Infected Patients Respond Poorly to Pneumococcal Vaccine

Antibody responses to pneumococcal vaccine are low among HIV-infected individuals, whether they receive it before they begin antiretroviral therapy (ART) or after at least 6 months of ART, according to a poster presented at the Infectious Diseases Society of America 49th Annual Meeting.

Published
04 November 2011
From
Medscape (requires registration)
← Prev12345...7Next →

Filter by country